Published in Emerg Infect Dis on January 01, 2012
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One (2013) 0.84
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009. Pediatrics (2012) 0.75
Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes "a" and "b". Can J Infect Dis Med Microbiol (2016) 0.75
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. Wkly Epidemiol Rec (2006) 2.57
Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis (1999) 2.32
Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000. MMWR Morb Mortal Wkly Rep (2002) 1.88
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis (2003) 1.76
Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children. J Clin Microbiol (1976) 1.49
Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995. MMWR Morb Mortal Wkly Rep (1996) 1.45
Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr (1992) 1.38
Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J (1993) 1.36
Comparison of outer membrane protein subtypes of Haemophilus influenzae type b isolates from healthy children in the general population and from diseased patients. J Clin Microbiol (1983) 1.34
The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics (2006) 1.27
Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect (2004) 1.15
Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR Morb Mortal Wkly Rep (2007) 1.10
School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis (2008) 0.97
Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage. Pediatrics (2011) 0.86
Haemophilus disease in Alaskan and Canadian children. Pediatr Infect Dis J (2010) 0.83
Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine. MMWR Morb Mortal Wkly Rep (2009) 0.83
The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. Epidemiol Infect (1999) 0.81
Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model. Epidemiol Infect (2004) 0.80
Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom. Epidemiol Infect (2007) 0.79
Occurrence of H. influenzae in Throats of Adults. Yale J Biol Med (1945) 0.78
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med (2003) 4.65
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis (2010) 3.61
Antimicrobial-resistant nocardia isolates, United States, 1995-2004. Clin Infect Dis (2010) 3.15
The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives. Am J Public Health (2008) 3.09
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis (2012) 2.74
Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis (2012) 2.64
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis (2012) 2.62
Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis (2004) 2.42
Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003. Arch Neurol (2006) 2.40
Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA (2012) 2.36
An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol (2003) 2.31
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis (2006) 2.30
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis (2003) 2.29
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20
Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol (2011) 1.94
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine (2012) 1.81
Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol (2009) 1.77
Early Impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med (2012) 1.69
A multisite study of the prevalence of HIV with rapid testing in mental health settings. Am J Public Health (2014) 1.67
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Endemic foodborne botulism among Alaska Native persons--Alaska, 1947-2007. Clin Infect Dis (2011) 1.66
Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg (2007) 1.65
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis (2005) 1.64
International Circumpolar Surveillance, an Arctic network for the surveillance of infectious diseases. Emerg Infect Dis (2008) 1.64
Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol (2006) 1.61
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis (2008) 1.60
Waning immunity to pertussis following 5 doses of DTaP. Pediatrics (2013) 1.58
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr (2013) 1.57
HIV infection and awareness among men who have sex with men-20 cities, United States, 2008 and 2011. PLoS One (2013) 1.55
Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis (2004) 1.51
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med (2009) 1.48
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol (2011) 1.47
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008. Vaccine (2011) 1.47
sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One (2011) 1.45
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis (2004) 1.43
Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply. Pediatr Infect Dis J (2010) 1.40
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine (2011) 1.40
Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol (2011) 1.38
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology (2010) 1.37
International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Emerg Infect Dis (2008) 1.34
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine (2007) 1.33
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Outbreak of invasive Haemophilus influenzae serotype a disease. Pediatr Infect Dis J (2005) 1.31
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis (2010) 1.31
Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. Clin Infect Dis (2011) 1.30
The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics (2006) 1.27
Novel Brucella strain (BO1) associated with a prosthetic breast implant infection. J Clin Microbiol (2007) 1.27
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics (2013) 1.25
Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology (2004) 1.25
Global epidemiology of invasive meningococcal disease. Popul Health Metr (2013) 1.25
Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Clin Infect Dis (2009) 1.25
Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin Infect Dis (2010) 1.24
Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics (2011) 1.24
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali. Cost Eff Resour Alloc (2009) 1.23
The yin and yang of paracetamol and paediatric immunisations. Lancet (2009) 1.22
Neisseria meningitidis serogroup W, Burkina Faso, 2012. Emerg Infect Dis (2014) 1.22
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis. BMC Infect Dis (2013) 1.21
Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J (2005) 1.19
Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg Infect Dis (2008) 1.19
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr (2015) 1.17
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis (2008) 1.16
2009 Pandemic influenza A H1N1 in Alaska: temporal and geographic characteristics of spread and increased risk of hospitalization among Alaska Native and Asian/Pacific Islander people. Clin Infect Dis (2011) 1.14
Evaluation of a volunteer sample in nasopharyngeal colonization surveys for Streptococcus pneumoniae in rural Alaska. Int J Circumpolar Health (2005) 1.14
Performance of a rapid antigen test (Binax NOW® RSV) for diagnosis of respiratory syncytial virus compared with real-time polymerase chain reaction in a pediatric population. J Clin Virol (2010) 1.14
Haemophilus haemolyticus isolates causing clinical disease. J Clin Microbiol (2012) 1.13
Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr (2012) 1.12
Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Pharmacoepidemiol Drug Saf (2007) 1.11
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine (2006) 1.10
Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Pediatrics (2003) 1.09
Patient satisfaction in the emergency department--a survey of pediatric patients and their parents. Acad Emerg Med (2002) 1.09